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ABSTRACT
Bloom syndrome (BS) is an autosomal recessive
disorder characterized by genomic instability and
the early development of many types of cancer.
Missense mutations have been identified in the
BLM gene (encoding a RecQ helicase) in affected
individuals, but the molecular mechanism and the
structural basis of the effects of these mutations
remain to be elucidated. We analysed five disease-
causing missense mutations that are localized in
the BLM helicase core region: Q672R, I841T, C878R,
G891E and C901Y. The disease-causing mutants
had low ATPase and helicase activities but their
ATP binding abilities were normal, except for Q672,
whose ATP binding activity was lower than that of
the intact BLM helicase. Mutants C878R, mapping
near motif IV, and G891E and C901Y, mapping in
motif IV, displayed severe DNA-binding defects. We
used molecular modelling to analyse these muta-
tions. Our work provides insights into the molecular
basis of BLM pathology, and reveals structural
elements implicated in coupling DNA binding to
ATP hydrolysis and DNA unwinding. Our findings will
help to explain the mechanism underlying BLM
catalysis and interpreting new BLM causing muta-
tions identified in the future.
INTRODUCTION
DNA helicases are important in DNA metabolism and are
involved in genome replication, DNA repair, recombina-
tion, transcription and telomere maintenance (1,2).
Helicases function as molecular motors. They use the
energy from nucleotide triphosphate (NTP) hydrolysis to
translocate along a nucleic acid strand, and separate
complementary strands of a nucleic acid duplex (3). The
conversion of the energy derived from NTP hydrolysis
into unwinding of double-stranded nucleic acids is
coordinated by seven sequence motifs (I, Ia, II, III, IV,
V and VI); these sequence motifs are features of super-
family-1 and -2 helicases (4). Motif 0, N-terminal to motif
I, is an additional motif that is also conserved in proteins
of the RecQ family (5). A similar element called a ‘Q
motif’ has also been characterized in DEAD-box RNA
helicases where it is important for NTP binding and
hydrolysis (6). Crystal structures of a catalytic core
fragment of Escherichia coli RecQ helicase show that
motifs 0, I and II are important in ATP binding and
hydrolysis by RecQ helicases (7). Studies of SF-1 helicases
(PcrA and Rep) have identiﬁed several highly conserved
residues in the seven motifs as being involved directly or
indirectly in linking DNA binding to ATP hydrolysis. The
crystal structures of HCV, PcrA, Rep and DEAD-box
protein Vasa revealed that motifs Ia, IV and V bind the
phosphate backbone of DNA (8–11). Several highly
conserved residues in motif IV, including two Arg residues
and one Asn residue in PcrA and Rep, have been observed
to interact directly with ds or ssDNA (10,12). Although
no crystal structure of the RecQ helicase–DNA com-
plex is available, it is widely thought that RecQ
helicases bind DNA in a similar manner to other helicases
(SF-1 and SF-2). Most RecQ family proteins have a
conserved RecQ-Ct domain immediately downstream
from the conserved seven signature motifs that is unique
to the RecQ family helicases (13). The RecQ-Ct
subdomain, as detailed in the E. coli RecQ crystal
structure, contains a platform of alpha helices with four
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2+ ion and
winged helix motif (7). The helicase and RecQ-Ct domains
combine to form the catalytic ‘helicase core’ domain
of E. coli RecQ, containing the sequence motifs necessary
for its ATPase and DNA unwinding activities.
The RecQ family of DNA helicases has received much
attention in the past few years because mutations in three
RecQ helicases are associated with genome instability and
cancer susceptibility, and give rise to the human disorders:
Bloom syndrome (BS) (14), Werner syndrome (WRN) (15)
and Rothmund–Thomson syndrome (16,17).
Bloom syndrome is a rare autosomal recessive genetic
disorder. It is characterized by growth deﬁciency, unusual
facies, immunodeﬁciency, male sterility/female subfertility
and an increased risk of a broad spectrum of cancers
that develop at a young age. Although Werner syndrome
and Rothmund–Thomson syndrome individuals also
develop cancers, BS is the only RecQ-related disorder
that causes cancers of the types observed in elderly general
populations (18). Cells from BS patients exhibit chromo-
somal instability characterized by elevated rates of sister
chromatid exchanges (SCEs), loss of heterozygosity and
quadriradials (19). BS cells exhibit hyper-recombination
and abnormalities in DNA replication involving an
extended S phase and accumulation of an abnormal
proﬁle of replication intermediates. Thus, the BLM
protein is expected to play a central role in one or more
DNA metabolic pathways (20).
BLM, the gene mutated in BS, encodes a 1417 amino
acid protein which has amino acid sequence similarities
with the RecQ family of DNA helicases (Figure 1) (14).
The natural DNA substrates of BLM in the cell have
not been identiﬁed. However, in vitro studies demonstrate
that BLM unwinds the canonical Watson–Crick duplex,
and recognizes and disrupts alternative DNA structures
including Holliday junctions, triple helices and the highly
stable G-quadruplex (21–25). In addition to its DNA
unwinding activity, BLM displays a strand annealing
activity (26). BLM’s helicase activity is necessary for the
correction of the genomic instability of BLM cells (27).
Like other RecQ family helicases, BLM interacts physi-
cally and functionally with numerous proteins in the cell
to perform its diverse functions (20).
Various disease-linked mutations have been identiﬁed in
the BLM gene. The most frequent mutations include stop
codons, insertions and deletions that generate frameshift
mutations and missense mutations. Seven disease-causing
missense mutations have been described: Q672R, I841T,
C878R, G891E, C901Y, C1036F and C1055S (14,28–31).
Five of these mutations have been mapped to the seven
sequence motifs that are conserved (Figure 1A). The
seminal work of the Keck laboratory on the atomic
structure of RecQ helicase has provided new insight into
the structural consequences of some missense mutants (7).
Biochemical and structural characterizations of the
mutations C1036F and C1055S, localized in the RecQ-Ct
domain, have shown that both mutations aﬀect sites
directly involved in the formation and stability of the
zinc binding domain; the zinc binding domain plays an
essential role in protein folding and DNA substrate
recognition and discrimination (32). Q672R and I841T,
mutations localized in the helicase core domain,
have been characterized using partially puriﬁed
enzymes (27,33): both mutants have been shown to be
deﬁcient in ATPase and helicase activities, but the mole-
cular basis of their mutagenic eﬀects remains to be
determined. In this study, we analysed the ﬁve disease-
causing mutations found in the helicase core, using mole-
cular modelling and biochemical and biophysical app-
roaches. Studies of these mutants help elucidate the
possible molecular bases of the BLM disease-causing
mutations, and also to provide information on the con-
served mechanismsemployedbytheRecQfamily helicases.
MATERIALS AND METHODS
Plasmid construction and site-directed mutagenesis
A plasmid for producing the BLM helicase core consisting
of amino acid residues 642–1290 was generated by
inserting the corresponding gene between the NdeI and
XhoI sites of the expression plasmid pET15b (Novagen).
The resulting plasmid, pET-BLM
642–1290, was used as the
target for site-directed mutagenesis. All point mutations
were constructed by ‘splicing by overlap extension’ as
described (34) with the desired mutations in the internal
mutagenic primers (Table 1). To avoid undesired muta-
tions, PCR fragments were sequenced by the dideoxy
method performed by MWG (MWG Biotech, Germany).
Protein production and purification
All proteins (wild type and mutants) were puriﬁed by the
following protocol. A single colony of the E. coli strain
(BL21(DE3)-condonplus) producing the protein was
grown overnight in 10ml of LB containing 80mg/ml
ampicillin and 34mg/ml chloramphenicol at 378C. An
aliquot of 0.1ml of this culture was diluted into 1l of pre-
warmed LB, and the cells were grown to the mid-
exponential phase (A600 of 0.5–0.6) at 378C. Protein
production was induced by the addition of isopropyl-1-
thio-a-D-galactopyranoside to a ﬁnal concentration of
0.25mM, and the culture was incubated with shaking at
188C for 18h. The cells were harvested by centrifugation
and suspended in a ﬁnal volume of 25ml of the lysis buﬀer
(50mM Tris–HCl, pH 7.5, 500mM NaCl, 0.1% Triton X-
100, PMSF 0.1mM and 10% glycerol). Cells were lysed by
passage through a French pressure cell and the samples
were sonicated to reduce viscosity. To remove any
insoluble materials, the cell lysate was centrifuged twice
at 15000g for 45min. The soluble extract was applied to a
column containing 20ml of Ni-NTA resin (Qiagen), and
the subsequent puriﬁcation procedures were performed
with FPLC system (A ¨ KTA Puriﬁer) at 188C. The column
was washed with lysis buﬀer until the UV absorbance at
280nm became stable. Bound proteins were eluted with
300ml linear gradient of imidazole (0.02–0.4M).
Fractions containing the proteins were identiﬁed by
SDS-polyacrylamide gel electrophoresis. Pooled fractions
were concentrated and further puriﬁed by FPLC size
exclusion chromatography (Superdex 200, Amersham
Bioscience). The puriﬁed proteins were electrophoresed
on SDS-polyacrylamide gels and visualized with
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Figure 1. (A) Schematic presentation of distribution of the identiﬁed mutant alleles in BLM patients (red). Domain organization of the BLM protein
is shown above the mutations. (B) Mutation map of helicase catalytic cores of BLM and RecQ from E. coli. Alignment was performed using
CLUSTALW and reﬁned manually. Conserved residues are highlighted in blue and similar residues are highlighted in marine green. The secondary
structure elements of RecQ from E. coli are indicated with alpha-helices appearing as cylinders and strands as arrows. Lobes 1 and 2 of the helicase
domain are respectively coloured blue and green, the zinc binding domain red and the WH domain gold. The seven conserved helicase motifs are
boxed and labelled in grey. The conserved aromatic-rich loop sequence is boxed in purple under the label ARLoop. The upper line numbering
indicates residue positions in the sequence of BLM and the underside line numbering, in italics, refers to the sequence of E. coli RecQ. Sites of all the
missense mutations causing Bloom syndrome are highlighted in red with the observed mutations underlined in red above the sequence. Other
mutation sites tested in BLM are indicated by an orange point inside a grey box. All the residues that have been mutated and studied to date in
E. coli RecQ are indicated by a black point in a yellow box.
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puriﬁed proteins were determined by the Bio-Rad dye
method using bovine serum albumin as the standard.
DNA substrates preparation
PAGE-puriﬁed oligonucleotides listed in Table 1 were
purchased from Proligo (France). Duplex DNA substrates
were prepared as described previously (32). Brieﬂy,
250mM DNA substrates were denatured in 1 TE
containing 1M NaCl or 1M KCl by heating at 958C for
10min. The denatured DNA was then annealed at 378C
for 48h. The annealed products were separated by 8%
non-denaturing PAGE with buﬀer containing 10mM KCl
and at 48C for 12h with constant current of 20mA.
ATPase assay
ATPase activity was assayed by measuring the release
of free phosphate during ATP hydrolysis (35,36). The
reaction was carried out in ATPase reaction buﬀer (50mM
Tris–HCl, pH 8.0, 3mM MgCl2, 0.5mM DTT) at 378Ci n
a volume of 100ml. The reactions were initiated by the
addition of enzymes into a reaction mixture containing
0.5mM ssDNA (nt, 60-mer oligonucleotide) and the
indicated concentration of ATP. The reaction was stopped
by transferring 80ml aliquots from the reaction mixture
every 30s into a hydrochloric solution of ammonium
molybdate. The liberated radioactive g
32Pi was
extracted with a solution of 2-butanol:benzene:acetone:
ammonium molybdate (750:750:15:1) saturated with
water. An aliquot (60ml) was removed from the organic
phase and the radioactivity was quantiﬁed using a liquid
scintillation counter.
Helicase assay
Radiometric assay. DNA helicase reactions were carried
out at 378C in reaction mixtures containing 25mM
HEPES-NaOH, pH 7.5, 25mM CH3CO2Na, 7.5mM
(CH3CO2)2Mg, 2mM ATP, 1mM DTT, 0.1mg/ml BSA
and the appropriate
32P-labelled partial duplex DNA
substrate (10 fmol, 3000c.p.m./fmol). Reactions were
initiated by addition of the indicated concentration of
BLM proteins and incubated at 378C for 30min.
Reactions were terminated by the addition of 5mlo f
5 loading buﬀer (50mM EDTA, 0.5% SDS, 0.1%
xylene cyanol, 0.1% bromophenol blue and 50% gly-
cerol). The products of helicase reactions were resolved
on 12% (w/v) polyacrylamide gel (acylamide to bis-
acrylamide ratios 19:1). The gel was run in TBE buﬀer
(90mM Tris, 90mM boric acid and 1mM EDTA, pH 8.3)
at 100V for 2h at 48C.
Fluorometric assay. Stopped-ﬂow DNA-unwinding assays
were performed as described (37). Brieﬂy, a Bio-logic
SFM-400 mixer with a 1.5 mm 1.5mm cell (Bio-Logic,
FC-15) and a Bio-Logic MOS450/AF-CD optical system
equipped with a 150-W mercury-xenon lamp were used.
They were performed in two-syringe mode, where helicase
and duplex DNA substrates were preincubated in syringe
1 for 5min and ATP in syringe 4. Each syringe contained
unwinding reaction buﬀer (25mM Tris–HCl, pH 7.5at
258C, 50mM NaCl, 1mM MgCl2 and 0.1mM DTT)
and the unwinding reaction was initiated by rapid
mixing. The sequences of the two strands, labelled
with hexachloroﬂuorescein (H) and ﬂuorescein (F),
respectively, of the 56:16-mer DNA substrates were
50H-AATCCGTCGAGCAGAG(dT40)-30 and 30F-TTAG
GCAGCTCGTCTC-50. To convert the output data from
volts to percent unwinding, another experiment was
performed in the four-syringe mode, where helicase in
syringe 1, H-labelled ss oligonucleotides in syringe 2 and
F-labelled ss oligonucleotides in syringe 3 were incubated
in unwinding reaction buﬀer, the solution in syringe 4
being the same as in the above unwinding experiment.
Table 1. Sequences of oligonucleotides used for site-directed mutagenesis and DNA substrates
BLM Recombinant or mutagenic PCR primer (50-30)
WT
642–1290 F- GGAATTCATATGGAGCGTTTCCAAAGTCTTAGTTTTCCT
R- CCGCTCGAGTTACGATGTCCATTCAGAGTATTTCTGTAA
Q672R F- TTTAGAACTAATCGGCTAGAGGCGATC
R- GATCGCCTCTAGCCGATTAGTTCTAAA
I841T F- GTACAGAAGGACACCCTGACTCAGCTG
R- CAGCTGAGTCAGGGTGTCCTTCTGTAC
C878R F- AAGGTGGCATTTGATCGCCTAGAATGGATCAGA
R- TCTGATCCATTCTAGGCGATCAAATGCCACCTT
G891E F- CCATACGATTCAGAGATAATTTACTGC
R- GCAGTAAATTATCTCTGAATCGTATGG
C901Y F- TCCAGGCGAGAATATGACACCATGGCT
R- AGCCATGGTGTCATATTCTCGCCTGGA
DNA substrate Length DNA substrate sequence
HJ1 40 CCGTGATCACCAATGCAGATTGACGAACCTTTGCCCACGT
HJ2 40 ACGTGGGCAAAGGTTCGTCAATGGACTGACAGCTGCATGG
HJ3 40 CCATGCAGCTGTCAGTCCATTGTCATGCTAGGCCTACTGC
HJ4 40 GCAGTAGGCCTAGCATGACAATCTGCATTGGTGATCACGG
A 44 GCACTGGCCGTCGTTTTACGGTCGTGACTGGGAAAACCCTGGCG
B 45 TTTTTTTTTTTTTTTTTTTTTTAGCCGTAAAACGACGGCCAGTGC
F21 21 Fluo- GGGTTAGGGTTAGGGTTAGGG
6300 Nucleic Acids Research, 2007, Vol. 35, No. 18The ﬂuorescent signal of the mixed solution from the
four syringes was used to deﬁne 100% unwinding. The
standard reaction temperature was 258C and all concen-
trations listed were after mixing unless noted otherwise.
Data were ﬁtted with Equation (1)
AðtÞ¼A1 1   e kobs,1t   
þ A2 1   e kobs,2t   
, 1
where A1 (A2) and kobs,1 (kobs,2) represent, respectively, the
unwinding amplitude and rate of the fast (slow) phase.
DNA binding assay
Electrophoretic mobility shift assay. Binding reactions
(20ml) were conducted in standard binding buﬀer
(40mM Tris–HCl, pH 7.0, 1mM EDTA, 20mM NaCl,
8% glycerol and 20mg/ml bovine serum albumin). Protein
and DNA substrate concentrations are indicated in
the ﬁgure legends. Reactions were incubated for 30min
at room temperature. Non-denaturing loading dye (4mlo f
0.25% bromphenol blue in 30% glycerol) was added to
reaction mixes and the samples were loaded onto 6% non-
denaturating polyacrylamide gels (19:1). Electrophoresis
was carried out at a constant voltage of 14V/cm at 48C
in 1  TAE (40mM Tris acetate, 1mM EDTA, pH 8.0)
for 3h. The gels were dried and processed for
autoradiography.
Fluoresence polarization assay. DNA binding was studied
by ﬂuorescence polarization as described previously (37).
The assays were performed using a Bio-logic auto-titrator
(TCU-250) and a Bio-Logic optical system (MOS450/AF-
CD) in ﬂuorescence anisotropy mode. Various amounts
of proteins were added to 1ml of binding buﬀer con-
taining 1nM DNA substrate. Each sample was allowed
to equilibrate in solution for 1.5min, and ﬂuorescence
polarization was then measured. Titrations were per-
formed in a temperature-controlled cuvette at 258C. The
solution was stirred continuously by a small magnetic stir
bar throughout the titration process. The binding
isotherms were determined and ﬁt by Equation (2):
A ¼ Amin þð Amax   AminÞ
  
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2   4DTNPT
p
2DT
, 2
where A is the ﬂuorescence anisotropy at a given
concentration of RecQ, Amax is the anisotropy at
saturation, Amin is the initial anisotropy,
=DT+NPT+KD, DT is the total concentration of
DNA, PT is the concentration of the enzyme in the
binding solution and KD is the apparent dissociation
constant.
ATP binding assay
The ATP binding aﬃnity of BLM
642–1290 and the mutants
was measured by nitrocellulose ﬁlter binding as described
in reference (38). The assays were performed at 48C with
a ﬁxed amount of ATP and various concentrations of the
proteins. Nitrocellulose ﬁlters (25mm) were washed with
0.5M NaOH for 10min, rinsed with double-distilled
water, and then equilibrated in wash buﬀer (40mM
Tris–HCl, pH 7.5/10mM MgCl2/50mM potassium
glutamate). The proteins (from 5 to 30 mM) were mixed
with ATP (200 mM) and [g-
32P]ATP in the absence of
DNA in 40mM Tris–HCl (pH 7.5)/10mM MgCl2/10mM
DTT/50mM potassium glutamate/10% glycerol in a total
volume of 20 ml. The reaction mixtures were incubated for
30min on ice, and 15ml aliquots were ﬁltered through
nitrocellulose ﬁlters. The membranes were washed twice
with 2ml of ice-cold wash buﬀer. The radioactivity bound
to the nitrocellulose membrane was measured in a liquid
scintillation counter. The stoichiometry of ATP binding
was calculated from the radioactivity count.
Strandannealingassay
DNA strand annealing activity was measured according
to Cheok et al. with some modiﬁcations (26). Brieﬂy,
the assay was performed using fully complementary
oligonucleotides, one of which was 50 32P-end-labelled.
Reactions were carried out in a reaction buﬀer (20ml)
containing 20mM Tris–acetate, pH 7.9, 50mM KOAc,
10mM Mg(OAc)2, 1mM DTT, 50mg/ml BSA and the
indicated protein concentration. The reaction was
initiated by adding the unlabelled oligonucleotide, imme-
diately followed by incubation at 378C for 15min and was
stopped by the addition of stop buﬀer (50mM EDTA, 1%
SDS and 0.1mg/ml of proteinase K). The resulting DNA
products were analysed as described for the helicase
assays.
RESULTS
Structural modelof theBLM helicase core-DNA complex
We have previously modelled the atomic structure of the
BLM helicase core of the apo-BLM enzyme. We further
modelled the 3D structure of the BLM helicase core by
homology modelling using both amino acid sequence
alignment (Figure 1B), and the template structure of
E. coli RecQ helicase in complex with ATP-g-S (7).
Bernstein and colleagues compared several 3D structures
of helicases in complexes with ATP/DNA, and the E. coli
RecQ atomic structure. Using these comparisons, they
proposed a model for the RecQ-DNA complex:
(i) dsDNA is bound in a depression formed between the
zinc ﬁnger and WH domains and (ii) ssDNA is bound
both to the top of the RecA-like lobe 1, where ATP
also binds, and lobe 2 (7,39). This DNA binding topology
is diﬀerent from that of SF1 helicases PcrA and Rep
(10,12). The recently published structure of the HRDC
domain of E. coli RecQ, and the study of the aromatic-
rich loop of RecQ mutants are consistent with this model
(40). We introduced a heteroduplex DNA into the BLM
structure, made adjustments to our structure using
Bernstein and colleagues’ model for DNA binding to
E. coli RecQ, and obtained a model of BLM in complex
with DNA and ATP (Figure 2). Most of the disease-linked
mutations are localized in or near the ATP and DNA
binding sites (Figure 2). The structural environment
of each mutated residue is indicated in Figure 3. The
molecular structure of BLM–DNA complex provides
an excellent model for elucidating the biophysical basis
of known BLM-causing mutations.
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mutantproteins
The recombinant helicase core of BLM protein made up
of residues 642–1290 (BLM
642–1290) displays similar
biochemical properties, both in vitro and in vivo, to that
of the full length BLM protein (41). The BLM
642–1290
fragment, similar to the full-length protein, is a DNA-
dependent ATPase and an ATP-dependent DNA helicase
that displays a 30-50 polarity. The BLM
642–1290 fragment
eﬃciently unwinds Holliday junctions and suppresses
spontaneous and UV-induced illegitimate recombination
in E. coli (41). We used the BLM
642–1290 protein fragment
to study the functional consequences of the ﬁve disease-
causing mutations (Q672R, I841T, C878R, G891E and
C901Y). The mutants were produced by site-directed
mutagenesis, and the mutated residues were identical
to those identiﬁed in BS patients. The part of the BLM
gene corresponding to amino acid residues 642–1290
(BLM
642–1290), and the mutated genes, containing the
ﬁve mutations, were expressed in an E. coli pET
expression system. The recombinant proteins were puriﬁed
using Ni-agarose aﬃnity and gel ﬁltration chromatogra-
phy. All mutants and the BLM
642–1290 fragment were
over-produced and puriﬁed to homogeneity. The mutant
protein preparations were between 90 and 95% pure
(Figure 4). Mutant Q672R displayed a high level of
aggregation, even in the presence of the chemical
chaperone betaine (42) (data not shown). This suggests
that Q672R is involved in protein folding (see below).
Helicase activity assay
Wild type and mutants of the BLM
642–1290 fragment were
tested for their helicase activities by electrophoresis
mobility-shift assay. Mutant C878R exhibited a detectable
helicase activity but only at high protein concentrations
(Figure 5A). All other mutants displayed no signiﬁcant
DNA unwinding activity at the protein concentrations
used in this study (Figure 5A). As BLM helicase unwinds
forked duplex DNA more eﬃciently than partial duplex
DNA, we characterized the DNA unwinding activity
of the ﬁve mutants with forked duplex DNA substrates.
BLM
642–1290 unwound forked DNA eﬃciently. C878R
unwound DNA only at high protein concentrations, and
the other mutants did not unwind partial duplex DNA
(Figure 5A and B). We studied the DNA unwinding
activity of these mutants with various protein concentra-
tions. Under similar experimental conditions, only C878R
was able to unwind DNA to similar levels as
the BLM
642–1290 protein fragment, and this required a
10-fold greater protein concentration (Figure 5C). This
suggests that the mechanisms of impairment of DNA
unwinding diﬀer between C878R, which retain intrinsic
DNA unwinding ability under certain conditions, and the
other mutants. Previous studies have shown that the BLM
can act in concert with topoisomerase IIIa to resolve
recombination intermediates containing double Holliday
junctions (21,24), a potential physiological DNA substrate
of BLM. Since BLM helicase activity is required for
dissolution of the double Holliday junction structure,
we then compared the Holliday junction resolution
activity of wild type and mutant BLM
642–1290 proteins.
Figure 5D shows that the intact BLM
642–1290 was able to
disrupt four-way junctions to the component single
strands, whereas all the mutant BLM proteins failed
to do so.
To measure the unwinding amplitude, and the unwind-
ing rate, we used rapid stopped-ﬂow ﬂuorescence assays.
The assays were based on ﬂuorescence resonance energy
transfer (FRET) (43) to measure the helicase activity of
BLM
642–1290 and BLM mutants under similar experimen-
tal conditions. Multiple turnover kinetic studies were
performed with all the mutants and BLM
642–1290.
BLM
642–1290 -catalyzed unwinding of a 16bp duplex was
biphasic, and we could best ﬁt time courses using the sum
of two exponential terms (Figure 5E). The observed rate
constants of the fast and slow phases were 0.52 and
0.05s
 1, respectively, for BLM. Under similar experi-
mental conditions, mutants E841T, G891E and C901Y
did not unwind DNA, whereas Q672R clearly displayed
helicase activity. C878R displayed DNA unwinding
activity at high protein concentrations, consistent
with results obtained by radiometric assay (Figure 5E
and Table 2).
Figure 2. Mutation sites in the modelled BLM structure. Ribbon
drawing of the BLM helicase catalytic core, obtained after reﬁnement
of the structure generated by the Modeller computation (see text for
details) with a trace of a partially unwound DNA molecule in a
possible orientation, shown in purple and grey. This model is used to
consider possible relationships between structure and enzyme activities.
The N-terminal domains 1A (lobe 1) and 2A (lobe 2) are respectively
coloured blue and green, the zinc binding domain is red, and the WH
domain, gold. The conserved aromatic-rich loop is shown in blue-green.
Labels N and C refer to the N-terminus and C-terminus, respectively.
ATPgS is drawn in cream with a ball-and-stick representation, the
manganese ion is shown as a light green ball and the zinc ion in cyan.
Magenta spheres are the Ca positions of the ﬁve mutations studied
in this article and observed in patients suﬀering from Bloom syndrome.
Yellow spheres are the Ca positions of the two mutations in the zinc
binding domain studied previously.
6302 Nucleic Acids Research, 2007, Vol. 35, No. 18Figure 3. Environments of the ﬁve studied Bloom Syndrome mutation sites in the BLM structure model. For all panels of the ﬁgure, domains 1A
and 2A are in blue and green, respectively, and the zinc binding domain is in red. ATPgS is drawn as a ball-and-stick representation in cream, the
manganese ion is shown as a magenta ball and the conserved aromatic-rich loop is in cyan. The conserved motifs are coloured as follows: motif 0 is
drawn in orange, motif IV in gold and motif V in purple. The mutated residues are labelled ‘#’ and the one letter codes and positions of the
analogous residues in RecQ from E. coli are given in blue and in brackets. Possible interactions between neighbour atoms are indicated with dashed
lines. (A) Detailed view of the environment of the mutation site Q672 and the ATP-binding site. Residues believed to be involved in ATP binding or
hydrolysis are indicated. (B) Detailed view of the environment of I841. The conserved hydrophobic sites and the ATP binding site are shown. (C) Site
of C878 in the BLM structure model. Interactions between conserved residues, all involving LYS 869, are indicated as dashed lines. (D) Detailed view
of the environment of G891. The major interactions between the conserved residues R959 and D983 and between R982 and the phosphate moiety of
ATP are shown as dashed lines. (E) Detailed view of the environment of C901. Binding distances for the sulphur atoms of the cluster (C895, C901,
M904 and C944) are indicated with dashed lines. Conserved charged or polar residues in motif IV are also indicated. (F) Comparison of motif IV
in PcrA (cream) with that in BLM (gold). PcrA residues are highlighted in cream. Residue numbering for PcrA is indicated by the label ‘[PCRA]’.
A least squares comparison gave a RMSD of 1.7A ˚ for 75 atoms superimposed.
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BLM is a DNA-stimulated ATPase and ATP-dependent
helicase, so we next investigate the biochemical basis
for the reduced helicase activity of each of the mutant
proteins by assaying for the various sub-activities that
together constitute the overall DNA unwinding activity.
The ATPase activities of the ﬁve disease-causing BLM
mutant proteins were measured as described in ‘Materials
and Methods’ section . The rate constant (kcat), KM values
and the ATPase catalytic eﬃciencies (kcat/KM) for intrinsic
and DNA-stimulated ATPase activity were assayed by
varying the concentration of ATP substrate. The resulting
curves were ﬁtted using the Michaelis–Menten equation
(Figure 6, Table 2). We did not detect ATPase activity in
mutant proteins in the absence of a DNA cofactor (data
not shown). The kcat values of the G891E and C901Y were
36-fold lower than that of BLM
642–1290, indicating that
for both mutant proteins, the turnover rates for ATP
hydrolysis were signiﬁcantly lower. The kcat values of
Q672R, I841T and C878R were between 3.3 and 16.3s
 1
(Table 2). However, their KM values were higher than that
of BLM
642–1290 (Table 2). The ATPase activity of the
BLM protein is stimulated by DNA. Thus, the observed
low apparent kcat values of these mutant proteins may
have resulted from a low aﬃnity for either ATP or DNA.
To determine the structural basis for the lower ATPase
activity of these mutants, ATP binding aﬃnities of
BLM
642–1290 and mutant proteins were qualitatively
assayed by nitrocellulose ﬁlter binding. All mutant
proteins bound ATP with similar stoichiometry to that
of BLM
642–1290, except for Q672R (Table 2). Most mutant
proteins bound ATP normally, but were unable to
hydrolyze ATP eﬃciently. Thus, the low levels of ATP
hydrolysis by other mutant proteins cannot be due to
a failure of ATP binding. Q672R had a signiﬁcantly
poorer ATP binding activity (Table 2), suggesting that
Q672 is involved in ATP binding.
DNA bindingassay
Helicases are DNA-stimulated ATPases, so we investi-
gated the DNA binding ability of these mutants to
determine whether the lower ATPase and helicase
activities were a result of failure to bind DNA. We used
electrophoretic mobility-shift assays to probe the ability of
BLM proteins to bind ssDNA and dsDNA. Mutants
Q672R and I841T bound ssDNA and dsDNA with
aﬃnities similar to those of BLM
642–1290. DNA binding
by C878R, G891E and C901Y was signiﬁcantly weaker
than that by BLM
642–1290 (Figure 7). C901Y had a lower
aﬃnity for ssDNA than for dsDNA, but C878R had a
lower aﬃnity for dsDNA than for ssDNA (Figure 7). The
diﬀerence in ssDNA and dsDNA binding for C901Y and
C878R may reﬂect intrinsic energetic properties of these
mutants for DNA binding. To conﬁrm the diﬀerences
in ssDNA and dsDNA binding by these mutants and
measure their dissociation constants for DNA binding, we
used a ﬂuorescence anisotropy assay: we measured the
apparent Kd values under equilibrium conditions (44).
We titrated ﬂuorescein-labelled 36-mer ssDNA and
dsDNA with various concentrations of BLM
642–1290 and
mutant proteins. The resulting binding isotherms were
ﬁtted with Equation (2) (Figure 8). The apparent
dissociation constants determined from the titration
curves are consistent with the results obtained with the
radiometric assay. The binding aﬃnity of C901Y for
ssDNA was signiﬁcantly lower than that for dsDNA with
dissociation constants of 475nM for ssDNA and 122nM
for dsDNA. The mutant protein C878R had signiﬁcantly
lower dsDNA binding than ssDNA binding. Mutants
Q672R and I841T displayed DNA binding aﬃnity similar
to that of the BLM
642–1290.
Strandannealing assay
Recently, a novel strand annealing activity of BLM was
reported and it has been suggested to play an important
role in replication fork regression (26). To compare the
BLM-mediated strand annealing activity between the
BLM
642–1290 and mutant proteins, we incubated two
partially complementary single strand oligonucleotides
with increasing concentrations of puriﬁed proteins and
analysed the products on native polyacrylamide gels. The
results in Figure 9A showed that BLM
642–1290 and most
missense mutants, except for G891E, displayed signiﬁcant
strand annealing activity at protein concentrations above
80nM. More interestingly, some mutants such as C901Y
and Q672R exhibited stronger annealing activity than
that of BLM
642–1290. In accordance with the previous
studies, the strand annealing activities of the wild-type and
the mutants proteins are partially inhibited by ATP
(Figure 9B), except Q672R. This is consistent with the
fact that Q672R is deﬁcient in ATP binding.
Thus, we have characterized the enzymatic activities of
all the mutants. ATPase, helicase, ATP binding and DNA
binding activities of these proteins were expressed as ratios
relative to the wild-type enzyme in Figure 10.
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Figure 4. SDS-PAGE analysis of the puriﬁed BLM
642–1290 and various
mutants. The proteins (indicated above the ﬁgure) were resolved in
10% SDS-polyacrylamide gel and stained with Coomassie blue. The
amounts of the proteins used were 3.5mg for BLM, C878R and C901Y
and 1.5mg for I841T, G891E and Q672R. The positions of marker
proteins (in kDa) are indicated on the left.
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Figure 5. DNA unwinding activity of wild-type and mutant BLM proteins. (A C) Helicase activities revealed by radiometric assay using duplex
DNA and forked DNA. 50-
32P-labelled DNA substrate (1ng) was incubated at 378C with wild-type and the various mutants in helicase assay buﬀer.
The reactions were terminated after 30min and the samples were analysed by electrophoresis in a 12% non-denaturing polyacrylamide gel. The
concentrations of the proteins were between 0.25 and 60nM as indicated at the bottom of the gel panel, where C1 and C2 represent labelled ssDNA
and partial duplex DNA substrate, respectively. (D) Unwinding of the Holliday junction by BLM
642–1290 and the all mutants. Reaction mixtures
(20ml) in unwinding buﬀer contain 1nM DNA substrate, 1mM ATP and the indicated amounts of the proteins. The four-way DNA junction was
constructed from oligonucleotides HJ1, HJ2, HJ3 and HJ4. Reactions were carried out and analysed as described for A. HJ1, HJ2, HJ3 and HJ4
represent single-stranded, two-stranded, three-stranded and four-way junction substrate, respectively. (E) DNA unwinding activity by stopped-ﬂow
DNA unwinding assay. As described in the ‘Material and Methods’ section, 1nM 56:16-mer DNA substrate was pre-incubated with 20nM helicase
for 5min at 258C. The unwinding reaction was initiated by mixing with 1mM ATP. The ﬂuorescence emission of ﬂuorescein at 520nm (excited at
492nm) was monitored. The fraction of DNA unwound was obtained by normalization of the ﬂuorescence signal. The solid curves are the best ﬁt
of the data to Equation (1) and the values of A1 (A2) and kobs,1 (kobs,2) are given in Table 2.
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In this study, we describe the molecular consequences of
ﬁve mutations that cause Bloom syndrome. Combination
of the biochemical study and the molecular modelling
approaches improve our understanding of the molecular
basis of how these mutations aﬀect BLM enzymatic
functions, thereby perturbing the integrity and stability of
chromosomes. These analyses have also provided new
insight into how the RecQ family helicases couple DNA
binding to ATP hydrolysis and DNA unwinding, and how
this coupling is impaired in the BLM misense mutants.
Residue Q672is involvedin ATP binding
The BLM missense mutation, Q672R, is naturally
occurring and causes Bloom’s syndrome, and has been
mapped to motif 0 (14). Several additional mutations
found in various species have indicated that this residue is
crucial for enzyme function. The E. coli RecQ in complex
with ATPgS structure shows that motif 0 forms a loop
connecting two helices creating a pocket that accommo-
dates the adenine base of the ATPgS molecule. OE1 and
NE2 atoms of the C-terminal Gln residue 672 (Q672 in
BLM is equivalent to Q30 in E. coli RecQ) of motif 0 form
hydrogen bonds with the N6 and N7 atoms of the adenine,
speciﬁcally binding ATP. Consistent with the previous
results obtained with the partial puriﬁed full length BLM
(27,33), our data indicates that Q672R displays normal
DNA binding activity, but its ATPase activity is
signiﬁcantly impaired. This implicates Q672 in either
ATP binding or hydrolysis. The KM and kcat values
obtained from the ATP saturation curves show that the
Q672R turnover rate for ATP hydrolysis is similar to that
of the BLM
642–1290, but that its ATP binding aﬃnity is
signiﬁcantly lower. Our direct ATP binding experiment
Table 2. ATPase, helicase, DNA binding and ATP binding activities of the wild-type and mutant BLM proteins
Helicases ATPase Helicase DNA binding ATP binding
Vm KM kcat kcat/KM A1 kobs,1 A2 kobs,2 ssDNA dsDNA [ATP]/[Protein]
mM min
 1 mMs
 1 s
 1 mM
 1 %s
 1 %s
 1 nM nM
BLM
642–1290 164.2 9.3 80.7 2.0 13.7 169.5 62.8 0.6 0.52 0.01 23.2 0.6 0.05 0.01 7.2 0.4 9.8 1.1 1.02 0.23
Q672R 127.6 11.4 1755 127 10.6 6.0 16.2 0.1 0.03 0.01 10.9 0.8 15.3 1.9 0.22 0.04
I841T 39.8 7.4 ND
a 3.3 ND 12.1 1.2 14.8 1.5 1.01 0.15
C878R 196.5 11.5 3460 693 16.3 4.7 30.2 0.1
b 0.01 0.01 168 10 327 27 0.97 0.23
G891E 4.6 0.9 ND 0.38 ND 352 12 349 12 0.98 0.14
C901Y 5.8 0.8 ND 0.48 ND 475 25 122 18 0.89 0.27
aND: cannot be determined precisely. The ATP saturation curves of the BLM
642–1290 and its corresponding variant were ﬁtted by Michaelis–Menten,
Lineweaver–Burk and Eadie–Hofstee equations. The ATP saturation curves of BLM
642–1290, Q672R and C878R were ﬁtted well by the three
equations, yielding similar Vm and Km values, whatever the ﬁtting procedure. In contrast, for poorly active mutants, I841, G891E and C901Y, the
Lineweaver–Burk and Eadie–Hofstee plots were not linear. For these mutants, only the Vm values were precisely recovered by ﬁtting with
the Michaelis–Menten equation.
bData obtained with 150nM protein.
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Figure 6. ATP hydrolysis activity of the wild-type and mutant BLMs as
a function of ATP concentration. Experiments were performed in
ATPase assay buﬀer at 378C with 0.5mM ssDNA (nt, 60-mer
oligonucleotide) and 0.1 or 0.2mM of each enzyme. The ATP hydrolysis
was quantiﬁed as described in ‘Material and Methods’ section. Solid
lines represent the best ﬁt of the data to the Michaelis–Menten
equation. The apparent kcat and KM values obtained are summarized in
Table 2.
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Figure 7. Analysis of DNA binding activity of the intact and mutant
BLMs using electrophoretic mobility shift assay. One nanomole of
50-labelled ssDNA or dsDNA was incubated at room temperature for
20min with 2.5 to 160nM protein in unwinding buﬀer. Bound and free
DNA were separated by electrophoresis through a non-denaturing 15%
polyacrylamide and revealed by autoradiography.
6306 Nucleic Acids Research, 2007, Vol. 35, No. 18conﬁrms that the ATP binding ability of Q672R is
dramatically decreased. These ﬁndings are consistent
with the data from the crystal structure of E. coli RecQ
in complex with ATPgS (7) and our molecular modelling
structure of the BLM helicase core (Figures 2 and 3A).
The Q672R mutant protein tended to aggregate. This
suggests that either residue Q672 or ATP binding is
important in protein folding as the mutant protein Q672R
is deﬁcient in ATP binding.
Residue I841 contributes to stabilize theresidues involved
in ATPhydrolysis
Motifs I and II (Walker A and B motifs, respectively) are
highly conserved in SF-1 and SF-2 helicases, and have
residues that interact with MgATP/MgADP. Our mole-
cular BLM model, consistent with the crystal structures of
PcrA, Rep and E. coli RecQ helicases, shows that the
carboxyl of the highly conserved D795 coordinates the
Mg
2+ ion of Mg
2+-ATP through outer sphere interac-
tions, and that E796 may act as a catalytic base in ATP
hydrolysis (Figure 3B). Residues D795, E796, A797 and
H798 map in a loop connecting a b-strand and a a-helix in
our model. The spatial positions of the crucial residues
D795 and E796 are further stabilized by a conserved
hydrophobic pocket involving residues A797, and I841
(Figure 3B). Replacement of residue I with T in position
841 inserts a polar group that may disrupt the coherence
of this pocket, and aﬀect the interactions involving
residues D795, E796, A797 and H798 in motif II
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Figure 8. The anisotropy-based DNA binding isotherms of wild-type
and mutant BLM proteins. Fluorescence anisotropy values were
determined as a function of BLM concentration for 36 mer ssDNA
(A) and dsDNA (B) substrates. A total of 5nM ﬂuorescein-labelled
DNA was titrated with increasing amounts of BLM as described in the
‘Materials and Methods’ section. The solid lines represent the best ﬁts
of the data to the Equation (2). The apparent Kd, values are
summarized in Table 2.
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Figure 9. Strand annealing activity of BLM
642–1290 and mutant
proteins. (A) Strand annealing activity of BLM proteins was assayed
by the formation of a 23bp forked duplex. Two partially complemen-
tary oligonucleotides (0.5nM oligonucleotide A and B), one of which
was radiolabelled at the 50-end and the other was unlabelled, were
incubated with the indicated concentrations of BLM protein for 15min
at 378C in the helicase reaction buﬀer in the absence of ATP. The
reaction products were separated by 12% non-denaturing PAGE and
revealed by autoradiography. (B) Eﬀect of nucleotides on the BLM-
mediated ssDNA annealing. The reactions contained 100nM proteins
and were carried under the same conditions as in A. ATP concentration
was 2mM, as indicated in the left of the ﬁgure.
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Figure 10. Graphic representation of the relative enzymatic activity of
BLM mutants. Data points are the means of two to three experiments.
Nucleic Acids Research, 2007, Vol. 35, No. 18 6307(Figure 3B). These structural modiﬁcations may have
direct consequences on the orientation of motif II with
regard to the g-phosphate of ATP. The modiﬁcations may
disturb the position of E796, (equivalent to E147 in RecQ
from E. coli) which acts as the catalytic base that polarizes
a water molecule for attack on the g-phosphate of ATP.
The modiﬁcations may also aﬀect the position of D795
(equivalent to D146 in RecQ from E. coli) that coordi-
nates the catalytic ion Mg
2+ (7). Thus, the mutation
I841T may have an eﬀect on the positions of D795 and
E796, which are both predicted to be directly involved in
ATP binding and hydrolysis. This is in agreement with our
biochemical data showing that this mutation impairs the
ATPase and helicase activities whereas DNA and ATP
binding activities remain unchanged.
Residue C878 mayconnect the zincbinding motif and lobe2,
andto enhance DNA binding
The C878R mutant can unwind partial and forked duplex
DNA at high protein concentration and displays
low, but detectable ATPase activity. However, its
DNA binding ability is substantially below that of
the BLM
62–1290 fragment. The modelled BLM structure
reveals two structural features related to C878
(Figure 3C): (i) residue C878 is close to the hydrogen
bonds between K869 and D997, and its sulphur atom is
5.22A ˚ from the side chain of K869. The hydrogen bond
interactions between K869 and D997 are highly conserved
from bacteria to human, and may contribute to the
stabilization of the zinc binding motif relative to the lobe 2
of the helicase domain, thereby stabilizing DNA binding.
(ii) C878 is also part of an a-helix connected to a lysine-
rich loop (residues 869–873), which is unique to BLM. The
lysine-rich loop
869–873, comprising four lysine residues and
a proline, constitutes a ﬂexible and positively charged
surface and is totally accessible to solvent. This loop is
very close to the dsDNA binding sites in both the E. coli
RecQ helicase model and our BLM model, and may
contribute to DNA binding and substrate speciﬁcity. The
mutation C878R, involving a very large and very
positively charged residue, may interfere with the K869–
D997 hydrogen bond linking the zinc binding motif to
lobe 2, and thus displace the zinc binding motif from lobe
2, thereby aﬀecting DNA binding. Indeed, mutant C878R
displays a detectable unwinding activity at high protein
concentration indicating that its intrinsic ATPase and
helicase activities are not abolished, but that a high
protein concentration is required to enhance DNA
binding. We also measured ATPase activity of C878R
with increasing DNA concentration as additional indica-
tion of the ability of the mutant enzyme to bind DNA. We
found that the mutant C878R needs 12-fold higher
ssDNA concentration to achieve the same extent of
ATPase stimulation by the BLM
642–1290 (data not
shown). These various ﬁndings suggest that residue C878
may link the zinc binding motif and lobe 2 to enhance
DNA binding. The BLM protein preferentially unwinds
or migrates recombination intermediates, including
Holliday junctions and D loops; possibly, the molecular
basis for the pathological eﬀects of the C878R mutant is
that it fails to recognize, bind and unwind its substrate in
cells during the DNA transaction process.
Residue G891 isinvolved incoupling DNA binding and
ATP hydrolysis
The ATPase and DNA helicase activities and DNA
binding are severely compromised in G891R although
its ATP binding activity appears essentially normal.
This implicates G891 in the coupling of DNA binding
and ATP hydrolysis. Residue G891 is distant from the
ATP binding/hydrolysis sites, so it is reasonable to assume
that the mutation G891R causes long-distance structural
modiﬁcations, thereby aﬀecting ATP hydrolysis. Residue
G891 of motif IV contributes to a hydrophobic site with
several conserved residues that constitute parallel-strand
beta-sheets (Figure 3D). These hydrophobic interactions
probably greatly stabilize the spatial position of beta
strand 12. Residue R959 is on top of the beta strand 12
and forms a salt bridge with D983 which may spatially
restrict the position of the arginine residue 982, the only
residue of lobe 2 expected to be involved in ATP
hydrolysis (Figure 3D) (7,45). Replacement of the small
apolar glycine residue 891 with a large and positively
charged arginine residue undoubtedly destabilizes the
local conformation near position 891, particularly beta
strand 12 where R959 is implicated in stabilization of the
putative arginine ﬁnger. R959 is only 5A ˚ from residue
G891, so the side chain of the mutated 891 may directly
disturb R959 through charge repulsion. As a consequence,
R959 may not be properly oriented in the mutant to
interact with D983.
Replacement of G891 with an arginine not only impairs
ATP hydrolysis and DNA unwinding activities, but also
results in DNA binding defects. At ﬁrst glance, it is
surprising that G891 in motif IV contributes to DNA
binding. However, the crystal structures of Rep bound to
ssDNA, PcrA bound to a hybrid DNA with both single-
stranded and duplex segments, HCV helicase bound to
ssDNA and DEAD-box helicase Vasa in complex with
ssRNA indicate that motifs Ia and IV contribute
substantially to the speciﬁc interactions with oligonucleo-
tides. Several conserved residues in motif IV, including
Asn, Arg and Lys, are directly involved in oligonucleotide
binding (Table 3). No crystal structure of RecQ helicase in
complex with DNA is available, so it is hard to ascertain
whether G891 interacts directly with the oligonucleotide
or stabilizes the relevant b strands through hydrophobic
interactions, thereby ensuring a suitable conformation for
DNA binding (Figure 3D). In the light of our ﬁndings, it is
reasonable to suppose that G891 contributes to coupling
DNA binding to ATP hydrolysis. DNA binding may
result in a subtle change in the conformation of several b
strands around G891 and in particular b strand 12. R959
is on top of the b strand 12 and interacts with D983. The
spatial orientation of R959 may be altered upon DNA
binding, aﬀecting the arginine ﬁnger position through the
D983–R959 salt bridge and activating ATP hydrolysis.
This possibility is in good agreement with our bio-
chemical data showing that this mutation impairs ATPase,
DNA helicase and DNA binding activities. As the
6308 Nucleic Acids Research, 2007, Vol. 35, No. 18mutation does not signiﬁcantly disturb ATP binding, the
loss of helicase activity is presumably the consequence of
a coupling between DNA binding and ATP hydrolysis.
Residue C901 stabilizes thea-helix of motif IV which
is probablyinvolved inDNA binding
Residue C901 is in the central position of motif IV which
is composed by a strand connected to an a-helix
(Figure 3E). Crystal structures of several helicases in
complex with oligonucleotides have shown that some
conserved residues in motif IV are involved in DNA
binding (Table 3). PcrA and BLM display a similar fold of
motif IV. Residues R898 and R899 (equivalent to N361
and R365 from PcrA) of motif IV (Figure 3F) may play
a key role in ssDNA binding (Figure 3E). Moreover, the
a-helix of motif IV may swing as a rigid body due to
thermodynamic movement (Figure 3E). Such a mobile
a-helix may be unfavourable for DNA binding and must
be further restricted to a spatial position appropriate for
DNA binding. In our BLM molecular model, residue
C901 is associated with an intriguing cluster of 3 cysteines
and 1 methionine (C895, C901, M904 and C944). The
distances between the cysteine or methionine side-chain
sulphur groups are all 3.4A ˚ and close to the ideal distance
(2.35 0.09A ˚ ) for structural metal-coordination sites (46).
It is possible that the a-helices of the motif IV are
maintained in the spatial orientation appropriate for
DNA binding by this metal-binding motif including
C901. Preliminary biochemical characterization indicates
that Zn
2+ is not involved in the formation of the putative
metal-binding motif. The relevance of this putative metal-
binding motif and the nature of the metal are currently
under investigation in our laboratory. Alternatively, C901
may form disulﬁde bridges with one of its neighbour
cysteines to stabilize the a-helix of motif IV.
In mutant C901Y a medium-sized polar cysteine residue
(valine in RecQ from E. coli) is replaced with a large
and planar tyrosine residue with an OH group. This is
expected to disrupt the metal-binding motif or the putative
disulﬁde bridges and consequently destabilize the helix of
motif IV carrying residues that may be involved directly or
indirectly in DNA binding. This model predicts that the
residues in the helix are important for ssDNA binding,
contributing to the formation of the BLM–DNA complex.
Consistent with the model, mutant C901Y exhibited
signiﬁcant reduction in dsDNA binding and even greater
loss of ssDNA binding (Figures 7 and 8).
The C901 involved in the putative metal-binding motif
is not a conserved residue in RecQ family helicases.
ATPase and helicase activities are common to all DNA
helicases, so a fundamental question is how deﬁciency of
a particular helicase gives rise to the characteristic
biochemical, cellular, genetic and organismal conse-
quences observed in helicase mutants. It is plausible that
each helicase recognizes its own substrate in the cell: the
structural feature involved in motif IV in BLM may have a
physiological relevance in DNA substrate speciﬁcity
recognition.
Although Cheok and colleagues (26) did not observe the
strand annealing activity with BLM
642–1290, we did detect
the strand annealing activity with BLM
642–1290 at protein
concentrations above 80nM (Figure 9). More interest-
ingly, some mutants displayed stronger strand annealing
activity than the intact BLM
642–1290 fragment, demon-
strating that the DNA unwinding and the strand
annealing activities could be uncoupled. The same
phenomenon was also observed in RECQL4 protein
(47). The observations that the missense mutants lost
helicase activity, but still possess the strand annealing
activity indicated that the helicase activity or its coordina-
tion with the strand annealing is essential for the integrity
and stability of chromosomes.
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